The blow fill seal technology market is expected to grow from its estimated USD 3,107.8 million in 2024 to USD 5,258.5 million in 2034. Between 2024 and 2034, sales are expected to increase at a ...

The incidence and prevalence of genital herpes simplex virus (HSV) type 1 and 2 infections are high worldwide, contributing ...

The arrest in the slaying of UnitedHealthcare CEO Brian Thompson was the first step to putting his killer behind bars, though ...

Sweid One is a pivotal project for us, designed to raise the bar for commercial office space within JLT,” said Maher Sweid, ...

Teva Pharmaceutical Industries Ltd. ADR 0.84% $19.88B ...

November 2024 has seen a variety of biotech deals take place to advance therapies across different stages in development.

Bangalore: Biocon has sold Eighty Lacs equity shares of Syngene International Limited for Rs. 686 crores. The transacted ...

Palbociclib plus ET improved outcomes over chemotherapy ± ET maintenance in patients with high-risk, HR+, HER2- metastatic breast cancer.

Updated results from the DREAMM-7 trial support the use of belantamab mafodotin plus bortezomib and dexamethasone “as a potential new standard of care,” according to Vania Hungria, MD, PhD.

Saudi Arabia Pharmaceutical Drugs Market Set To Witness Significant Growth By 2024-2031:Pfizer Inc.,Sanofi S. A.,Beigene Saudi Arabia Pharmaceutical Drugs Market is estimated to be valued at US$ 12.60 ...

DelveInsight's Hematology Market Insights report provides the current and forecast market analysis, individual leading ...

Bangalore), DKZP Higher Primary School Sandspit, Bengre (Mangalore) and ZPHS Moosapet (Hyderabad) triumph among 200 government schools • For the last ...